BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Xencor 

111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery





 Company News
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO) 12/18/2014 6:13:06 AM
MorphoSys AG And Xencor Publish Final Results From Phase 1/2a Trial Of MOR208 (Xmab5574) In CLL/SLL At Xencor Annual Meeting 12/8/2014 7:40:19 AM
Xencor To Present At The 25th Annual Oppenheimer Healthcare Conference 12/5/2014 12:56:57 PM
Xencor To Present At The 2014 Deutsche Bank (DB) BioFEST Conference 11/25/2014 11:59:09 AM
Xencor Reports Third Quarter 2014 Financial Results 11/11/2014 7:40:47 AM
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting 11/6/2014 9:13:54 AM
Xencor To Present At The 2014 Credit Suisse Annual Healthcare Conference 11/4/2014 9:02:58 AM
Xencor To Host Third Quarter 2014 Financial Results Webcast And Conference Call 11/3/2014 7:37:26 AM
Xencor Regains All Rights From Amgen (AMGN) To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes 10/29/2014 6:16:06 AM
Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development And Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 9/3/2014 11:25:37 AM
12345678910...